Purpose: The pharmacology, pharmacokinetics, clinical efficacy, safety, drug interactions, dosage and administration, and place in therapy of atomoxetine in the treatment of attention-deficit ...

Strattera (atomoxetine) is an oral medication that healthcare providers may prescribe for attention deficit hyperactivity disorder (ADHD). This behavioral disorder can cause hyperactivity ...

Qelbree (viloxazine) and Strattera (atomoxetine) are two examples of non-stimulant ADHD medications. Though they work similarly, the two have a few differences, particularly in dosing and ...

Strattera (atomoxetine) is a brand-name oral capsule. The Food and Drug Administration (FDA) has approved Strattera to treat attention deficit hyperactivity disorder (ADHD) in adults and children ...

Although ADHD rates decrease with age, at least half of children with ADHD will continue to have symptoms through adulthood.

A study published June 26 in Science Translational Medicine adds to the growing pile of proteomics data implicating cellular processes such as autophagy, ubiquitination, endocytosis, and glycolysis as ...

They are also available as generics. Nonstimulant medication, such as the antidepressant bupropion (Wellbutrin and generic) or atomoxetine (Strattera), which is not available as a generic.

A new survey shows that more than half of people diagnosed with obstructive sleep apnea (OSA) aren’t satisfied with their ...

In this case, doctors might try a non-stimulant medication. Non-stimulants: The main second-line non-stimulant treatments are atomoxetine and guanfacine which increase the amount of a chemical in the ...

Get the latest Business News, Live Share & Stock Market Updates, Top News from India and across world. Read Top Business News ...

Atomoxetine is a nonstimulant approved for the treatment of ADHD in children and adults. While this agent has been shown to be effective compared with placebo, no study has proven efficacy ...

Qelbree (viloxazine) and Strattera (atomoxetine) are two examples of non-stimulant ADHD medications. Both Qelbree and Strattera are serotonin-norepinephrine reuptake inhibitors (SNRIs).